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a b s t r a c t
The economic impact of anthelmintic resistance was investigated in lambs by compar-
ing productivity parameters in groups of animals treated either with a highly effective
anthelmintic, or an anthelmintic to which three species of resistant worms were known
to be present. Ten farmlets, each stocked with 30 lambs, were rotationally grazed for 5
months, with monthly treatments of either albendazole, to which resistance existed, or a
new combination product containing derquantel and abamectin (DQL–ABA) towhich there
was no resistance. Stock on ﬁve farmlets were treated with each anthelmintic and produc-
tivity measures, including liveweights, body condition and faecal soiling were assessed
throughout. In addition, ﬂeece weights and information on carcass weight and quality was
collected at the end of the trial.
Anthelmintic efﬁcacy was measured at the last two treatment dates by faecal egg count
reduction test with larval cultures. Albendazole demonstrated efﬁcacies of 48.4% and
40.9% for Trichostrongylus spp. and Teladorsagia circumcincta respectively. By contrast, the
DQL–ABA treatments were >99% effective against all genera. The difference in live-weight
gain was 9kg in favour of the DQL–ABA treatments. This translated into a 4.7 kg increase in
carcass weight with a 10.4% increase in carcass value. Signiﬁcant differences in body condi-
tion scores, faecal breech soiling and ﬂeece weights were also recorded, all in favour of the
DQL–ABA treatments. The time required for 50% of the animals to reach a target live-weight
of 38kg was signiﬁcantly shorter (by 17 days) in those animals treated with DQL–ABA.The results show that the production cost of subclinical parasitism as a result of using an
anthelmintic product which is less than fully effective due to resistance can greatly exceed
the cost of routine testing of anthelmintic efﬁcacy and the adoption of new anthelmintic
classes. There is a strong case for many farmers to re-evaluate their position on some of
these issues in order to optimise ﬁnancial performance.
© 2011 Elsevier B.V. Open access under CC BY-NC-ND license.. Introduction
Gastrointestinal nematode parasites can have a sig-
iﬁcant impact on the productivity of grazing sheep
McLeod, 1995; Perry and Randolph, 1999) and parasitism
s considered the most signiﬁcant animal health issue
y New Zealand sheep farmers (Lawrence et al., 2007).
∗ Corresponding author. Tel.: +64 6 3518086; fax: +64 6 3518134.
E-mail address: tania.waghorn@agresearch.co.nz (T.S. Waghorn).
304-4017/© 2011 Elsevier B.V. Open access under CC BY-NC-ND license.
oi:10.1016/j.vetpar.2011.11.063While some farmers utilise strategies such as improved
nutrition, changes in animal genetics and grazing man-
agement to minimise the impact of parasites, control is
generally reliant on the administration of broad-spectrum
anthelmintic drenches, particularly in regionswhere inten-
sive agricultural systems are prevalent. Increasingly, the
effectiveness of these anthelmintics is being threatened by
the development of resistance to them in nematode popu-
lations.
Much research effort has been invested in under-
standing the factors which increase the development of
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anthelmintic resistance and how these might be managed
(Leathwick et al., 2009). However, adoption of resistance
management practices on New Zealand farms has gener-
ally been poor, and this appears to be due to an element of
confusion about what constitutes resistance management
(Lawrence et al., 2007) and to a lack of a clear economic
imperative to do so. Providing a general measure of the
impact of anthelmintic resistance on animal productivity is
difﬁcult because there are invariably differences in farming
systems, animal genetics and the size and pathogenicity of
different nematode populations. A recent study conducted
in New Zealand compared the productivity of lambs, under
a monthly preventive program of anthelmintic treatments
with either a new highly effective anthelmintic or one
to which resistant parasites were present. The cost of
anthelmintic resistance was in this case estimated at 14%
of the value of the carcass at slaughter (Sutherland et al.,
2010).
The aim of the current study was to extend our knowl-
edge of the cost of anthelmintic resistance by comparing,
under different conditions of pasture quality and quantity
to the previous study, productivity in lambs treated with
another highly effective anthelmintic compared to one to
which resistance was known to be present. By accumulat-
ing sufﬁcient evidence on the cost of using an anthelmintic
product which is compromised by resistance it should be
possible to convince farmers of the value of routine testing
for anthelmintic efﬁcacy, the ﬁrst step in any resistance
management programme, and of using products which are
fully effective.
2. Materials and methods
A replicated ﬁeld trial was run from March to September
2010 on the Flock House research farm near Bulls in the
Manawatu region of the North Island of New Zealand. Ten
farmlets, each of eight paddocks, were established and
rotationally grazed with lambs for the duration of the study.
All animals received a series of ﬁve treatments, at 28-
day intervals, with either a newly introduced combination
anthelmintic product (DQL–ABA, STARTECT®, Pﬁzer New
Zealand Ltd, Auckland, New Zealand) or with albendazole
(Albendazole, Merial Ancare New Zealand Limited, Auck-
land, New Zealand). The experimental design was therefore
two treatments with ﬁve replicates in a completely ran-
domised structure.
2.1. Site preparation
The site had been used in a previous study and was
known to be contaminated with benzimidazole-resistant
Teladorsagia (=Ostertagia)  circumcincta, Trichostrongylus
colubriformis and Nematodirus spathiger. To avoid any pos-
sible confounding of resistance levels as a result of the
previous study, paddocks were allocated to farmlets in a
restricted randomisation that ensured a balanced repre-
sentation of the previous treatment structure in all farmlets
i.e. two paddocks from each of the previous four treatments
were allocated to every farmlet.ology 186 (2012) 376– 381 377
2.2. Animals
Three hundred castrated male lambs were purchased
from external sources and transported to the research farm.
On arrival, all were treated orally with ivermectin (Ivomec
Liquid for Sheep and Goats®, Merial Ancare NZ Ltd) and
an albendazole + levamisole combination product (Arrest
Hi-Mineral®, Merial Ancare NZ Ltd) on consecutive days,
at the manufacturer’s recommended dose rates. Samples
taken for faecal nematode egg count (FEC) seven days post-
treatment conﬁrmed that these treatments had effectively
removed existing parasite burdens.
Lambs were then allocated to 10 groups of 30 based on
liveweight, before each of these groups was allocated to a
farmlet. All 30 animals were rotationally grazed on each
farmlet throughout the trial, with a shift approximately
every ﬁve to seven days. Lambs allocated to Treatment
1 were administered DQL–ABA, while Treatment 2 lambs
were given albendazole. Both products were administered
at the manufacturer’s recommended dose rate of 2.0, 0.2
and 4.75 mg/kg for DQL, ABA and albendazole, respectively.
All doses were calculated based on the heaviest lamb in
each mob  on the day of treatment.
Experimental manipulation of animals was approved
by the Grasslands Animal Ethics Committee, Palmerston
North, New Zealand (#12045). Under this approval any
animal which had a FEC >3000 epg, or which lost >10%
body weight between weighing (28 days), was  treated with
DQL–ABA and removed from subsequent analysis. Over the
duration of the trial this occurred in nine animals, all of
which remained on the site in order to keep animal num-
bers constant across farmlets.
2.3. Parasitology
Nematode populations in all the lambs were monitored
using FEC, conducted at 4-weekly intervals, which usually
coincided with the day lambs received their anthelmintic
treatments. The number of strongylid and Nematodirus spp.
eggs present was determined using a modiﬁed McMas-
ter method in which each egg counted represented 50 epg
(Lyndal-Murphy, 1993).
Seven to 10 days after each treatment, additional sam-
ples were collected for FEC in order to estimate the efﬁcacy
of the treatment. For the ﬁrst three drench dates only 10
animals from each farmlet were sampled, however, for the
last two dates all lambs were sampled. Efﬁcacy was esti-
mated by comparing the pre- and post-treatment mean
FEC for each group of lambs, and calculating the percentage
reduction in undifferentiated FEC.
To monitor the generic composition of eggs passed by
the lambs, faecal larval cultures were carried out after each
monthly faecal sampling as well as at the 4th and 5th
post-treatment samplings. Faecal material surplus to that
required for FEC was  bulked within each farmlet and incu-
bated at 24 ◦C for at least 14 days. Infective third-stage
larvae (L3) were extracted by baermannisation (Hendrix,
1998), concentrated in a water column by sedimentation
at 5 ◦C, and the generic composition of the ﬁrst 100 L3
recorded.
3 y Parasitology 186 (2012) 376– 381
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Fig. 1. Treatment mean faecal nematode egg counts (±95% CI) from mobs78 C.M. Miller et al. / Veterinar
Samples to estimate L3 numbers on pasture were col-
ected at the beginning and end of the experiment from 5
f the 8 paddocks in each farmlet. Pasture was  collected
y hand-‘plucking’ herbage samples while walking zigzag
ransects across each paddock, until 200–300 g had been
ollected. Larvae were extracted from the samples by baer-
annisation, identiﬁed to genus and counted.
.4. Productivity measures
Liveweights were recorded monthly for all animals. Fae-
al soiling around the breech (dags) was assessed visually
nd given a score between 0 and 5; a 0 indicating no soiling
nd a 5 indicating severe soiling of the breech and rear legs.
ody condition score was also assessed, on a 1–5 scale, by
anual palpation of the lower vertebrae as an indication
f the amount of fat covering the pelvic vertebrae (Shands
t al., 2009), with a score of 1 indicating very poor condi-
ion and a score of 5 indicating overly fat. These parameters
ere assessed on three occasions during the trial, at the
ime of the 1st, 3rd and 5th anthelmintic treatments. At the
nd of the trial, lambs were shorn and ﬂeece weights indi-
idually recorded. Animals were subsequently slaughtered
t a commercial abattoir, and carcass weights and standard
easures of quality recorded for analysis.
.5. Statistical analysis
The experimental unit in this experiment was the group
f lambs grazing each farmlet and its associated nematode
opulation. The design therefore involved two treatments
ith ﬁve replicates in a completely randomised structure,
ielding an ANOVA table with 1 degree of freedom for
reatment and 8 degrees of freedom for error. The data for
nalysis was the mean value for each farmlet.
Liveweight gain, body condition score, dag score, the
umber of L3 on pasture and the generic composition of
asture plucks were all analysed by ANOVA (proc GLM)
n Minitab (Minitab 15.1, Minitab Inc 2006, USA) using a
tatistical model which included treatment anthelmintic
DQL–ABA or albendazole). For lamb liveweight gains, ini-
ial weight was  included as a covariate in the model and for
eece weights the liveweight prior to shearing was  used as
 covariate. FEC at the time of each anthelmintic treatment
as compared by calculating a geometric mean (GM) FEC
or each farmlet, after transformation of the individual egg
ounts by Ln(x + 1), and testing for a difference in GM FEC
etween treatments by ANOVA as above. Post-treatment
ECs were not compared statistically because the number
f animals sampled was often low and the groups treated
ith DQL–ABA nearly always returned zero egg counts, and
herefore zero variance. Post-treatment FECs are however
ncluded in Fig. 1.
The proportion of different genera in the faecal cul-
ures was also analysed by ANOVA (proc GLM) but with
 model which included farmlet, time and treatment.
epeated measures analysis was not used because there
as an anthelmintic treatment between each time event
i.e. sampling) which would have eliminated, or partially
liminated, the worm burden after each measurement,
ffectively making the culture results independent.of  lambs treated ﬁve times with DQL–ABA (n = 5) (—-) or albendazole
(n  = 5) (– - –) over the period of the experiment. Arrows indicate the
anthelmintic treatment points.
Time to target weight data was  analysed in GenStat
(GenStat v12, VSN International Ltd, UK) using repeated
measures analysis of variance with the least signiﬁcant dif-
ference (LSD) reported at the 5% level. Logistic curves were
ﬁtted to the data with day from start as the explanatory
variable, and the time taken for 50% and 90% of the ani-
mals in each treatment group to reach the target weight
was  estimated using proc GLM with a binomial distribution
and probit link function.
3. Results
GM FEC did not differ between the two  treatments at
the start of the experiment (P = 0.386, Fig. 1). However, at
all subsequent treatments the albendazole treated groups
had GM FECs which were signiﬁcantly higher, or which
approached signiﬁcance, than the DQL–ABA treated groups
(P < 0.001, P = 0.007, P = 0.061 and P = 0.005 for treatment
times 2–5 respectively). These differences undoubtedly
reﬂected the different efﬁcacy of the two treatments, with
FEC in the albendazole-treated lambs remaining elevated
after each treatment while that of the DQL–ABA-treated
animals dropped to zero or near zero (Fig. 1).
The proportion of different genera present in the fae-
cal cultures did not differ between treatments (P > 0.30).
However, overall the proportions did change over time
(P < 0.001). Trichostrongylus was the dominant genus at the
start of the trial, making up 60% of the L3 present, whereas
T. circumcincta made up 90% of L3 recovered at the end.
To clarify how populations changed over time, FECs were
apportioned by the percentage of each genus found in the
matching faecal cultures to generate a FEC for each genus
over the duration of the trial (Fig. 2).
The efﬁcacy of the two anthelmintic products, based on
FEC reduction, was  markedly different (Fig. 1). DQL–ABA
had an average efﬁcacy over the whole trial of 99.9% and
100% while, albendazole had efﬁcacies of 30% and 72%,
against strongyles and Nematodirus spp., respectively. Fol-
lowing the last two  treatments, faecal cultures from all
the treated animals allowed the efﬁcacies against different
C.M. Miller et al. / Veterinary Parasitology 186 (2012) 376– 381 379
0
1
10
100
1000
10000
N
um
be
r o
f p
ar
as
ite
 e
gg
s
date
Fig. 2. Number of nematode eggs of each genus (Trichostrongylus – ,
Teladorsagia – , and Nematodirus – ) present in the pre drench cultures
20
25
30
35
40
45
50
55
60
liv
e 
w
ei
gh
t k
g
Date
there was  no difference between treatments in either thefor  the two treatments (—- (DQL–ABA) and – - – (albendazole)) over the
period of the experiment. Total FEC was allocated to different genera based
on the proportion of L3 recovered from faecal cultures.
strongyle genera to be determined. The average efﬁcacy,
over the last two treatments, against Trichostrongylus spp.
was 99.7% and 48.4% for DQL–ABA and albendazole, respec-
tively; while for T. circumcincta efﬁcacies were 99.9% and
46.2%, respectively.
There was no difference between treatments in the
condition or faecal soiling scores at the start of the trial
(condition scores, 2.19 vs 2.26 and faecal soiling scores
0.32 vs 0.10 for the DQL–ABA and Albendazole treat-
ments respectively, P > 0.2). However, at the third and ﬁfth
treatment dates the DQL–ABA-treated lambs had higher
condition scores and lower faecal soiling scores than the
albendazole-treated lambs (Table 1).
Fleece weights at the end of the trial were signiﬁcantly
heavier in the DQL–ABA groups (P < 0.01), producing 360 g
more wool per animal, than the albendazole-treated ani-
mals.
Over the duration of the trial the animals treated with
DQL–ABA gained an average of 9 kg liveweight more than
those treated with albendazole (P < 0.001, Fig. 3). This
difference in liveweight translated into a difference in
carcass weights at slaughter of 4.7 kg heavier (P < 0.001)
for the DQL–ABA-treated animals, with a mean fat depth
Table 1
Mean values for production and parasite factors for each treatment with
their associated P values.
Parameter DQL–ABA Albendazole P value
Mean faecal egg counts
(epg)
199.4 660.0 0.001
Overall liveweight gain
(kg)
25.43 16.43 0.001
Fleece weights (kg) 2.02 1.66 0.001
Carcass weight (kg) 23.36 18.64 0.001
Carcass value (NZ$) 111.60 100.04 0.001
Fat depth (mm)  11.35 7.78 0.001
Condition score at 3rd
treatment
2.7 2.3 0.026
Final condition score 3.41 2.44 0.001
Faecal soiling score at
3rd treatment
0.72 1.804 0.002
Final faecal soiling
score
1.387 1.528 0.010Fig. 3. Mean liveweights (±95% CI) of lambs treated with either DQL–ABA
(—-) or albendazole (– - –) over the period of the trial. Anthelmintic treat-
ment points are indicated by arrows.
3.6 mm  (P < 0.001) greater, than that on the albendazole
animals. The overall price gain for the DQL–ABA animals
was NZ$11.56 per animal.
The time taken by animals in the two  treatments
to reach a target weight of 38 kg differed signiﬁcantly
(P = 0.01; Fig. 4). The time required for 50% of the animals
to reach 38 kg was  17 days (±0.5) shorter in the DQL–ABA-
treatment groups than in those treated with albendazole.
Similarly, the time for 90% of the animals to reach tar-
get weight in the DQL–ABA treatments was 34 days (±1)
shorter than for the albendazole treated animals.
Pasture sampling at the start of the experiment indi-
cated no statistically signiﬁcant difference in the number
(P = 0.165) or generic composition of the L3 popula-
tions on each farmlet (P > 0.4 for both T. circumcincta
and Trichostrongylus spp. and P = 0.121 for Nematodirus
spp.) (Table 2). Similarly, at the end of the experimenttotal number of L3 (P = 0.755) or their generic composi-
tion (P = 0.147–0.796) (Table 2). There was, however, a
LSD
0
20
40
60
80
100
0 20 40 60 80 10 0 12 0 14 0 16 0
Pr
op
or
tio
n 
of
 a
ni
m
al
s 
ab
ov
e 
38
 
kg
Days from sta rt of trial
Fig. 4. Fitted logistic curves showing the progression of animals achieving
the target weight of 38 kg when lambs were treated with DQL–ABA (—-
)  or albendazole (– - –) over the course of the trial. The least signiﬁcant
difference (LSD) at the 5% level is given for the difference between the
treatments.
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Table 2
Mean parasite numbers and proportional genera mix  on the pastures at the start and end of the experiment for both treatments. Tela – Teladorsagia, Trich
–  Trichostrongylus, Coop – Cooperia, Haem – Haemonchus, Oeso/Chab – Oesophagostomum/Chabertia, Nem – Nematodirus.
Treatment L3/kg dry matter Tela Trich Coop Haem Oeso/Chab Nem
Start DQL–ABA 3357 18.7 7.0 0.0 0.0 0.0 73.3
Albendazole 1690 24.0 13.4 0.0 0.0 0.0 62.5
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ccurred on three of the DQL+ABA farmlets with numbers
7 L3/kg dry matter (P = 0.047).
. Discussion
The production cost of using an anthelmintic which
s not achieving the expected levels of efﬁcacy due to
nthelmintic resistance has been clearly demonstrated.
ost notable in this study was the reduced liveweight gain
f 9 kg over the trial period. This translated into a reduced
arcass weight of 4.7 kg, which equated to a 10.4% reduc-
ion in carcass value. The effect of reduced parasite control
as also seen in a range of other performance variables
uch as body condition, breech soiling and ﬂeece weights.
The difference in liveweight gain measured in this trial
as greater than observed in previous studies into the
ost of anthelmintic resistance. Leathwick et al. (2008),
acchi et al. (2001) and Sutherland et al. (2010) recorded
eductions of 3 kg, 1.3 kg and 2.8 kg in liveweight gains,
espectively, from using anthelmintics which were com-
romised by the presence of resistance. These are all
roadly similar but lower than the difference found in this
xperiment. This is likely due to a greater overall parasite
hallenge from L3 on the pastures at the start of this trial
Table 2), as indicated by the high FEC (Fig. 1) i.e. FECs in
his study were generally higher throughout than those
eported by Sutherland et al. (2010) and Macchi et al. (2001)
hich ﬂuctuated around 100 and 500 epg, respectively.
A signiﬁcant ﬁnding from this study was that, despite
oth groups of animals having relatively high FECs, all the
ambs gained weight and appeared visually to be in good
ealth. For example, the albendazole-treated lambs grew
t an average rate of >110 g/day, and at the end of the
tudy had an average body condition score of 2.44. This
s important because many New Zealand farmers believe
hey will be able to detect an anthelmintic resistance prob-
em in the performance of their stock. As a result, most
armers are reluctant to meet the cost of routine testing
or anthelmintic resistance on their farms, and many have
ever done so (Lawrence et al., 2007). This lack of informa-
ion regarding the resistance status of nematodes on their
arm translates into a reluctance to implement resistance
anagement practices. The results of this study demon-
trate that even in the presence of established resistance
n several nematode species, the losses accruing due to the
resence of resistance can greatly exceed the cost of testing
ithout any obvious visual signs of parasitism. Similarly,
ost New Zealand farmers are reluctant to make use of
he two new classes of anthelmintic, now available for use
n sheep in New Zealand (Mason et al., 2009; Little et al.,4 9.4 6.5 0.0 13.6
3 0.0 0.0 0.3 4.1
2010), on the basis of price. However, the cost of using
either of these new products, which can be relied upon
to give high efﬁcacy, is substantially less than the level of
production loss shown in this study.
It was notable that over the course of the trial, L3 num-
bers on pasture declined, and there was no difference
between treatments at the ﬁnal comparison. This is likely to
reﬂect the trial being run over the autumn-winter period,
when development of nematode eggs passed onto pas-
ture is at its lowest (Vlassoff et al., 2001). Thus, while the
albendazole-treated animals would have deposited more
nematode eggs onto pasture than the DQL–ABA-treated
animals, this was not translated into a difference in L3 chal-
lenge to the grazing lambs because most of the eggs did
not develop. Had the trial been run over the late spring to
autumn period, it would reasonably have been expected
that the use of a less than fully effective anthelmintic
would have resulted in increased L3 numbers on pasture
in the autumn. In a study conducted by Leathwick et al.
(2008),  increasing levels of infection resulting from fail-
ure of albendazole to control pasture contamination by
resistant nematodes resulted in clinical parasitism and a
premature conclusion to the study in order to avoid ethical
issues. Had this aspect of using a less than fully effec-
tive anthelmintic been included in the current study it
is likely that the observed productivity differences would
have been even larger than presented here.
The timing of the trial is also the likely reason for the
observed change in nematode genera present in the faecal
cultures over the course of the trial (Fig. 2). As T. cir-
cumcincta is able to develop at colder temperatures than
Trichostrongylus spp. (O’Connor et al., 2006), its eggs can
continue to develop to L3 throughout the winter, albeit at
a much reduced rate (Waghorn et al., 2011). This would be
consistent with the observed increased proportion of T. cir-
cumcincta L3 on pasture in August (Table 2) and a greater
proportion of this nematode in the infected lambs (Fig. 2).
As sheep develop a strong immunity to Nematodirus spp.
as they age, this species was largely absent from the faecal
cultures by the end of the trial (Fig. 2), even though it was
still represented in the L3 populations on pasture (Table 2).
Lambs in New Zealand are usually drafted for slaugh-
ter as they reach a speciﬁc target weight, optimally around
38 kg liveweight. The time required for animals to reach
this target weight differed between treatments (Fig. 4).
The opportunity to draft lambs to slaughter sooner would
bring additional beneﬁts to the farmer. Being able to sell
animals sooner allows the farmer additional production,
animal management and ﬁnancial opportunities i.e. more
pasture is available to feed the remaining animals, support
the introduction of new stock or conserve for feed as hay
y Parasit
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or silage. The value of these opportunities has not been
estimated in the current study.
In conclusion, a loss in productivity due to subclin-
ical parasitism has been clearly demonstrated by these
results. Importantly, this loss, as seen in an earlier study
(Sutherland et al., 2010), far exceeded the cost of routine
testing of drench efﬁcacy on a farm and/or the use of the
new anthelmintic classes which are now available for use in
New Zealand and other countries. There would appear to be
a case for farmers to re-evaluate their stance on these issues
as it is becoming clear that the potential losses caused by
using an anthelmintic which is compromised by resistance
can greatly exceed the cost of ensuring that effective treat-
ments are used.
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